Graphene Oxide nanomaterials alter gene expression of tumour suppressor (TP53 and CDKN1A) and anti-apoptotic/pro-apoptotic BCL2 genes in human lymphocytes from patients with chronic pulmonary diseases – asthma, COPD, and lung cancer – and those of healthy individuals

17 Oct 2019
9:35-9:55

Graphene Oxide nanomaterials alter gene expression of tumour suppressor (TP53 and CDKN1A) and anti-apoptotic/pro-apoptotic BCL2 genes in human lymphocytes from patients with chronic pulmonary diseases – asthma, COPD, and lung cancer – and those of healthy individuals